Asset Allocation

As of December 31, 2025.
Type % Net
Cash 0.00%
Stock 83.88%
Bond 7.25%
Convertible 0.00%
Preferred 0.19%
Other 8.68%
View Asset Allocation
Start Trial

Market Capitalization

As of December 31, 2025
Large 83.47%
Mid 12.31%
Small 4.22%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 88.88%    % Emerging Markets: 1.03%    % Unidentified Markets: 10.09%

Americas 27.74%
27.42%
Canada 2.45%
United States 24.98%
0.31%
Mexico 0.18%
As of December 31, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 51.03%
United Kingdom 11.62%
38.75%
France 13.96%
Germany 4.86%
Ireland 2.87%
Italy 5.31%
Netherlands 5.96%
Spain 2.80%
Switzerland 2.94%
0.48%
Turkey 0.48%
0.18%
Israel 0.10%
Nigeria 0.03%
United Arab Emirates 0.03%
Greater Asia 11.14%
Japan 0.00%
1.12%
Australia 1.12%
9.78%
Hong Kong 0.86%
Singapore 1.25%
South Korea 3.08%
Taiwan 4.59%
0.24%
India 0.20%
Unidentified Region 10.09%

Bond Credit Quality Exposure

AAA --
AA --
A --
BBB --
BB --
B --
Below B --
    CCC --
    CC --
    C --
    DDD --
    DD --
    D --
Not Rated --
Not Available --
Short Term --
No Data Available
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
25.80%
Materials
2.09%
Consumer Discretionary
1.49%
Financials
22.23%
Real Estate
0.00%
Sensitive
46.05%
Communication Services
20.68%
Energy
6.83%
Industrials
4.86%
Information Technology
13.69%
Defensive
19.12%
Consumer Staples
3.19%
Health Care
8.12%
Utilities
7.80%
Not Classified
9.04%
Non Classified Equity
0.09%
Not Classified - Non Equity
8.94%
As of December 31, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of December 31, 2025
Type % Net
Government 4.14%
Corporate 51.65%
Securitized 37.02%
Municipal 0.00%
Other 7.20%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term --
Less than 1 Year --
Intermediate --
1 to 3 Years --
3 to 5 Years --
5 to 10 Years --
Long Term --
10 to 20 Years --
20 to 30 Years --
Over 30 Years --
Other --
No Data Available
View Bond Maturity Exposure
Start Trial